Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNK2 | Q07912 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.38 |
| ▸ | DHFR | P00374 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | NPY2R | P49146 | 1/20 | 0.33 |
| ▸ | NPY4R | P50391 | 1/20 | 0.33 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.33 |
| ▸ | ACP1 | P24666 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29951257 | 0.87 | CA1 (0.40) | TNK2MEN1KMT2ACA1CA2 | |
| SCHEMBL3500438 | 0.86 | TNK2 (0.44) | TNK2MEN1KMT2AHSD11B1DHFR | |
| SCHEMBL2938910 | 0.84 | MEN1 (0.40) | TNK2MEN1KMT2AHSD11B1DHFR | |
| SCHEMBL29950815 | 0.82 | DHFR (0.46) | TNK2MEN1KMT2AENPP2HSD11B1 | |
| SCHEMBL222919 | 0.81 | MEN1 (0.43) | TNK2MEN1KMT2ACA1CA2 | |
| SCHEMBL15093765 | 0.81 | MEN1 (0.43) | TNK2MEN1KMT2ACA1CA2 | |
| SCHEMBL15093959 | 0.81 | MEN1 (0.43) | TNK2MEN1KMT2ACA1CA2 | |
| SCHEMBL15376865 | 0.81 | TNK2 (0.36) | TNK2MEN1KMT2AHSD11B1DHFR | |
| SCHEMBL15869184 | 0.80 | TNK2 (0.40) | TNK2MEN1KMT2AHSD11B1DHFR | |
| SCHEMBL7363974 | 0.80 | MEN1 (0.58) | MEN1KMT2ACA1CA2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119463098-A | Polyurethane prepolymer and composition based on supermolecule weaving crosslinking and preparation method thereof | 浙江大学杭州国际科创中心 | 2025-02-18 | — | — | CN | claimed |
| US-12619147-B2 | Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, pattern forming method, and method for manufacturing electronic device | FUJIFILM CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | UNIV YALE (US) | 2026-04-30 | — | — | US | disclosed |
| US-12612371-B2 | Sigma-1 receptor ligands and therapeutic uses thereof | UNIVERSITE DE STRASBOURG (FR) | 2026-04-28 | — | — | US | disclosed |
| CN-114450631-B | Actinic-ray-or radiation-sensitive resin composition, actinic-ray-or radiation-sensitive film, pattern forming method, and method for manufacturing electronic device | 富士胶片株式会社 | 2025-06-03 | — | — | CN | disclosed |
| CN-113493694-B | Compound, liquid crystal composition and liquid crystal display element | 石家庄诚志永华显示材料有限公司 | 2025-03-11 | — | — | CN | disclosed |
| CN-119569549-A | 2-Phenyl naphthalene derivative and application thereof in preparation of anti-liver cancer drugs | 浙江大学 | 2025-03-07 | — | — | CN | disclosed |
| US-12234402-B2 | Mesogen compounds | TRANSITIONS OPTICAL, LTD. (IE) | 2025-02-25 | — | — | US | disclosed |
| CN-119463098-A | Polyurethane prepolymer and composition based on supermolecule weaving crosslinking and preparation method thereof | 浙江大学杭州国际科创中心 | 2025-02-18 | — | — | CN | disclosed |
| CN-113166649-B | Mesogenic compounds | 光学转变有限公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2005095544-A1 | LIQUID CRYSTAL COMPOUNDS, LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2005-10-13 | — | — | WO | disclosed |
| EP-1501514-A2 | PROTEIN KINASE MODULATORS AND METHODS OF USE | Exelixis, Inc. (US) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003093297-A2 | PROTEIN KINASE MODULATORS AND METHODS OF USE | EXELIXIS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-0832082-B1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ASTRAZENECA AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| US-6258817-B1 | PRODRUGS, HYPOTENSIVE AGENTS AND CARDIOVASCULAR DISORDERS | ZENECA LTD. (GB) | 2001-07-10 | — | — | US | disclosed |
| US-6060475-A | Substituted pyrazin-2-yl-sulphonamide-(3-pyridyl) compounds and uses thereof | ZENECA LIMITED (GB) | 2000-05-09 | — | — | US | disclosed |
| US-5866568-A | ENDOTHELIN RECEPTOR ANTAGONIST ACTIVITY | ZENECA LIMITED (GB) | 1999-02-02 | — | — | US | disclosed |
| EP-0832082-A1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ZENECA LIMITED (GB) | 1998-04-01 | — | — | EP | disclosed |
| US-5668137-A | N-heterocyclic sulfonamides having endothelin receptor activity | ZENECA LTD. (GB) | 1997-09-16 | — | — | US | disclosed |
| WO-1996040681-A1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ZENECA LIMITED (GB) | 1996-12-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612371-B2 | Sigma-1 receptor ligands and therapeutic uses thereof | SIGMAR1, OPRL1, OPRM1 | TNK2 3198/4885MEN1 4568/4885KMT2A 3285/4885 |
| US-12619147-B2 | Actinic ray-sensitive or radiation-sensitive resin composition, actinic ray-sensitive or radiation-sensitive film, pattern forming method, and method for manufacturing electronic device | RAD51, COL1A1, CROCC | TNK2 1156/4885MEN1 380/4885KMT2A 4005/4885 |
| US-20260115296-A1 | COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES | CRBN, VHL, ADRM1 | TNK2 1577/4885MEN1 3186/4885KMT2A 2541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.